| Literature DB >> 36249979 |
Reza Esmaeilzadeh Kenari1, Razie Razavi1.
Abstract
Bougainvillea spectabilis extract (BSE), a rich source of bioactive compounds like phenolic, flavonoid, and anthocyanin, was used for encapsulation with Urtica dioica L. seed gum. The extract was obtained using shaking, bath, and probe ultrasound. The results showed that probe ultrasound extract was more efficient, as reflected by the higher value of total phenolic (4354.15 mg GAE/100 g FW), flavonoid (2431.25 mg CE/100 g FW), and anthocyanin content (106.57 mg CGE/100 g FW). BSE was encapsulated in U. dioica L. seed gum at 1:1 and 1:2 core to coating ratio. In both DPPH radical scavenging and FRAP assay, higher antioxidant activity was observed in the encapsulated extract than in the free extract. Encapsulated extracts exhibited 87.9 nm average diameter (polydispersity index below 0.23) and negative zeta potential. The average minimum inhibitory concentration (MIC) of nanoparticles against Staphylococcus aureus, Escherichia coli, Listeria monocytogenes, and Salmonella enterica was 112.5, 87.5, 112.5, and 87.5 μg/ml, respectively, while MIC of the free extract against S. aureus and E. coli was 150 and 125 μg/ml, respectively. The phenolic compounds are gradually released from the nanoparticles in the gastric and small intestine phase, whereas free extract released phenolic compounds quickly after entering the gastric phase. Considering antioxidant/antimicrobial activity and release properties, nanoparticles with a 1:1 ratio of core to coating had the potential to use as an effective natural preservative agent in food products besides the delivery of bioactive compounds to the human body.Entities:
Keywords: bioactive compounds; bioavailability; controlled release; nanoemulsion; nanoparticle
Year: 2022 PMID: 36249979 PMCID: PMC9548349 DOI: 10.1002/fsn3.2944
Source DB: PubMed Journal: Food Sci Nutr ISSN: 2048-7177 Impact factor: 3.553
Extraction yield (EY), total phenolic (TPC), flavonoid (TFC), and anthocyanin content (TAC) of Bougainvillea spectabilis extract (BSE)
| Extraction method | EY (%) | TPC (mg GAE/100 g FW) | TFC (mg CE/100 g FW) | TAC (mg CGE/100 g FW) |
|---|---|---|---|---|
| Shaking | 6.12 ± 0.8c | 2115.76 ± 5.4c | 946.51 ± 3.7c | 28.31 ± 2.0c |
| Bath ultrasound | 10.56 ± 1.1b | 2870.83 ± 6.3b | 1405.39 ± 4.2b | 69.48 ± 4.2b |
| Probe ultrasound | 16.37 ± 1.2a | 4354.15 ± 5.4a | 2431.25 ± 3.5a | 106.57 ± 3.5a |
Note: Different superscript lowercase letters indicate statistically significant difference (p < .05).
Abbreviations: CE, quercetin equivalent; CGE, cyanidin‐3‐glucose equivalent; FW, fresh weight; GAE, gallic acid equivalent.
Antioxidant activity of free and nanoencapsulated Bougainvillea spectabilis extract (BSE)
| Evaluation method | Free extract | 1:1 | 1:2 | BHT |
|---|---|---|---|---|
| DPPH (IC50, mg/L) | 486.12 ± 3.31a | 457.55 ± 4.19b | 462.93 ± 3.80b | 32.39 ± 2.26c |
| FRAP (μM Fe+2/g) | 4.22 ± 0.12a | 4.09 ± 0.25b | 4.13 ± 0.32b | 2.97 ± 0.18c |
Note: Different superscript lowercase letters indicate statistically significant difference (p < .05).
Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of free and nanoencapsulated Bougainvillea spectabilis extract (BSE) (mg/ml)
| Bacteria | Free extract | Nanoencapsulated extract (core to coating ratio) | ||||
|---|---|---|---|---|---|---|
| 1:1 | 1:2 | |||||
| MIC | MBC | MIC | MBC | MIC | MBC | |
|
| 750a | 875b | 500a | 625a | 625a | 625a |
|
| 750a | 875b | 500a | 625a | 625a | 625a |
|
| 625b | 750b | 375b | 500b | 500b | 500b |
|
| 625b | 750b | 375b | 375b | 500b | 500b |
Note: Different superscript lowercase letters indicate statistically significant difference (p < .05).
Particle size, zeta potential, polydispersity index, and encapsulation efficiency of Bougainvillea spectabilis extract (BSE) nanoemulsion
| Core to coating ratio | Particle size (nm) | PDI | Zeta potential (mV) | Encapsulation efficiency (%) |
|---|---|---|---|---|
| 1:1 | 99.3 ± 0.5a | 0.227 ± 0.01a | −31.6 ± 1.5a | 83.4 ± 0.8a |
| 1:2 | 76.5 ± 0.7b | 0.198 ± 0.01b | −38.2 ± 1.2b | 76.6 ± 0.4b |
Note: Different superscript lowercase letters indicate statistically significant difference (p < .05).
FIGURE 1Surface electron morphology of nanoencapsulated Bougainvillea spectabilis extract (BSE). Nanoemulsion with core to coating ratio (a) 1:1 and (b) 1:2
FIGURE 2In vitro release of phenolic compounds from free and nanoencapsulated Bougainvillea spectabilis extract (BSE). (a) Gastric digestion, (b) small intestine digestion